A Randomized, Double-Blind, Placebo-Controlled Trial of Niacinamide for Reduction of Phosphorus in Hemodialysis Patients | Zendy

Steven Cheng | Zendy; Daniel O. Young | Zendy; Yihung Huang | Zendy; James A. Delmez | Zendy; Daniel W. Coyne | Zendy

Open Access

A Randomized, Double-Blind, Placebo-Controlled Trial of Niacinamide for Reduction of Phosphorus in Hemodialysis Patients

Author(s) -

Steven Cheng,

Daniel O. Young,

Yihung Huang,

James A. Delmez,

Daniel W. Coyne

Publication year - 2008

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.04211007

Subject(s) - medicine , hyperphosphatemia , niacinamide , placebo , niacin , hemodialysis , endocrinology , crossover study , urology , gastroenterology , calcium , surgery , biochemistry , nicotinamide , chemistry , alternative medicine , enzyme , pathology

Niacinamide inhibits intestinal sodium/phosphorus transporters and reduces serum phosphorus in open-label studies. A prospective, randomized, double-blind, placebo-controlled crossover trial was performed for assessment of the safety and efficacy of niacinamide.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research